Published in Proc Natl Acad Sci U S A on August 03, 1999
Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res (2002) 40.03
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell (2002) 17.32
Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A (2001) 13.30
The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics (2006) 12.45
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst (2009) 10.91
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol (2007) 10.49
Coexpression analysis of human genes across many microarray data sets. Genome Res (2004) 9.38
Initial impact of the sequencing of the human genome. Nature (2011) 9.18
The molecular classification of multiple myeloma. Blood (2006) 8.77
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res (2005) 8.73
Epidemiology of basal-like breast cancer. Breast Cancer Res Treat (2007) 7.08
Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93
The Stanford Microarray Database: data access and quality assessment tools. Nucleic Acids Res (2003) 6.31
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol (2007) 5.81
Coupled two-way clustering analysis of gene microarray data. Proc Natl Acad Sci U S A (2000) 5.55
Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci U S A (2000) 5.38
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell (2009) 5.24
A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol (2002) 5.15
Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. Genome Res (2000) 4.95
GEPAS: A web-based resource for microarray gene expression data analysis. Nucleic Acids Res (2003) 4.82
The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation (2002) 4.64
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer (2007) 4.44
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood (2005) 4.04
TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell (2005) 3.75
Choosing the right cell line for breast cancer research. Breast Cancer Res (2011) 3.57
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55
Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol (2011) 3.33
Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med (2008) 3.31
Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A (2001) 3.19
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer (2007) 3.16
Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res (2006) 2.95
A DNA microarray survey of gene expression in normal human tissues. Genome Biol (2005) 2.90
Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol (2002) 2.87
Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A (2003) 2.87
Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis (2008) 2.86
Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia (2000) 2.84
The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci U S A (2000) 2.82
Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci U S A (2003) 2.70
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res (2008) 2.69
Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One (2008) 2.66
Recursive partitioning for tumor classification with gene expression microarray data. Proc Natl Acad Sci U S A (2001) 2.66
Machine learning and its applications to biology. PLoS Comput Biol (2007) 2.57
Gene expression patterns in ovarian carcinomas. Mol Biol Cell (2003) 2.55
Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol (2004) 2.49
Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis. BMC Genomics (2002) 2.42
Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol (2006) 2.40
Practical implications of gene-expression-based assays for breast oncologists. Nat Rev Clin Oncol (2011) 2.38
Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics (2002) 2.31
A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response. PLoS One (2009) 2.29
A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res (2011) 2.26
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res (2009) 2.26
Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res (2001) 2.25
Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci U S A (2002) 2.15
Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin Cancer Res (2010) 2.15
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res (2007) 2.12
Functional classification analysis of somatically mutated genes in human breast and colorectal cancers. Genomics (2008) 2.11
Interactive exploration of microarray gene expression patterns in a reduced dimensional space. Genome Res (2002) 2.07
Next station in microarray data analysis: GEPAS. Nucleic Acids Res (2006) 2.05
Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev (2009) 2.00
The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol (2010) 1.96
A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res (2012) 1.92
Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol (2008) 1.89
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am J Pathol (2002) 1.89
Deciphering cellular states of innate tumor drug responses. Genome Biol (2006) 1.83
Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci U S A (2000) 1.82
Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci U S A (2005) 1.78
Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci U S A (2009) 1.78
Stromal responses among common carcinomas correlated with clinicopathologic features. Clin Cancer Res (2013) 1.75
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma. Haematologica (2010) 1.73
CleanEx: a database of heterogeneous gene expression data based on a consistent gene nomenclature. Nucleic Acids Res (2004) 1.73
Breast cancer - one term, many entities? J Clin Invest (2011) 1.72
Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. J Proteome Res (2006) 1.66
The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res (2008) 1.59
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat (2011) 1.58
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas. Breast Cancer Res (2012) 1.56
Using DNA microarrays to study host-microbe interactions. Emerg Infect Dis (2000) 1.55
Systematic learning of gene functional classes from DNA array expression data by using multilayer perceptrons. Genome Res (2002) 1.55
Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer. Genome Biol (2007) 1.54
Validation of a novel, fully integrated and flexible microarray benchtop facility for gene expression profiling. Nucleic Acids Res (2003) 1.52
Survival analysis with high-dimensional covariates. Stat Methods Med Res (2009) 1.50
The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. J Interferon Cytokine Res (2010) 1.48
Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc Natl Acad Sci U S A (2001) 1.48
Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res (2010) 1.47
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.46
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res (2010) 1.43
Expression profiling of human tumors: the end of surgical pathology? J Mol Diagn (2001) 1.43
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res (2010) 1.39
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. PLoS One (2009) 1.37
A common reference for cDNA microarray hybridizations. Nucleic Acids Res (2002) 1.35
Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics (2005) 1.34
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study. Mod Pathol (2011) 1.33
Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women. Breast Cancer Res Treat (2011) 1.33
Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst (2009) 1.31
Coactivator function defines the active estrogen receptor alpha cistrome. Mol Cell Biol (2009) 1.29
Generating and navigating proteome maps using mass spectrometry. Nat Rev Mol Cell Biol (2010) 1.29
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res (2009) 1.28
DNA amplification method tolerant to sample degradation. Genome Res (2004) 1.28
Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer. Breast Cancer Res (2012) 1.27
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48
Exploring the metabolic and genetic control of gene expression on a genomic scale. Science (1997) 60.15
The transcriptional program of sporulation in budding yeast. Science (1998) 37.23
Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A (1996) 24.18
A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res (1996) 23.16
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
Exploring the new world of the genome with DNA microarrays. Nat Genet (1999) 19.05
STATs and gene regulation. Science (1997) 16.55
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Data management and analysis for gene expression arrays. Nat Genet (1998) 8.60
Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev (1997) 5.57
Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev (1996) 5.17
The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol (1993) 4.18
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A (1997) 4.11
Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A (1996) 3.62
Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst (1977) 3.35
Contact inhibition and malignancy. Nature (1979) 3.16
Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J (1985) 2.47
Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem (1986) 2.37
Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol (1990) 2.13
MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res (1997) 2.12
Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol (1997) 2.01
Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. Am J Clin Pathol (1986) 1.86
Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci (1994) 1.85
Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. Exp Cell Res (1993) 1.84
Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer (1995) 1.81
Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci (1998) 1.77
Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene (1996) 1.71
Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (B1, Bp35), a type III integral membrane protein. J Exp Med (1988) 1.50
Probing lymphocyte biology by genomic-scale gene expression analysis. J Clin Immunol (1998) 1.46
TGF beta induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects. J Cell Physiol (1993) 1.41
Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol Biol Cell (1997) 1.37
Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ (1996) 1.36
The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer. Breast Cancer Res Treat (1998) 1.21
High-voltage electron microscopy of human diploid fibroblasts during ageing in vitro. Morphometric analysis of mitochondria. Exp Cell Res (1984) 1.20
Expression of v-src in mammary epithelial cells induces transcription via STAT3. Biochem J (1998) 1.10
Accelerated growth and senescence of arterial endothelial cells expressing the small molecular weight heat-shock protein HSP27. FASEB J (1995) 1.08
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Molecular portraits of human breast tumours. Nature (2000) 94.14
Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48
Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics (1989) 79.44
Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet (1980) 75.25
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell (1998) 62.20
Exploring the metabolic and genetic control of gene expression on a genomic scale. Science (1997) 60.15
The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res (2004) 54.37
The transcriptional program of sporulation in budding yeast. Science (1998) 37.23
Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell (2000) 36.09
Two differentially regulated mRNAs with different 5' ends encode secreted with intracellular forms of yeast invertase. Cell (1982) 25.10
Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet (2000) 24.22
Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A (1996) 24.18
A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res (1996) 23.16
Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature (2001) 21.55
Genetic and physical maps of Saccharomyces cerevisiae. Nature (1997) 21.48
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
Genetic engineering in vivo using translocatable drug-resistance elements. New methods in bacterial genetics. J Mol Biol (1977) 20.29
SGD: Saccharomyces Genome Database. Nucleic Acids Res (1998) 20.26
A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector. Gene (1987) 19.68
Sterile host yeasts (SHY): a eukaryotic system of biological containment for recombinant DNA experiments. Gene (1979) 19.39
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
Exploring the new world of the genome with DNA microarrays. Nat Genet (1999) 19.05
Integrating functional genomic information into the Saccharomyces genome database. Nucleic Acids Res (2000) 18.52
Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci U S A (2000) 18.42
Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A (2001) 17.36
A common language for physical mapping of the human genome. Science (1989) 17.36
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet (1999) 14.96
Using the Saccharomyces Genome Database (SGD) for analysis of protein similarities and structure. Nucleic Acids Res (1999) 13.65
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genet (2001) 13.05
DNA arrays for analysis of gene expression. Methods Enzymol (1999) 12.50
Gene expression informatics--it's all in your mine. Nat Genet (1999) 12.35
Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science (1987) 12.20
Mutagenesis by insertion of a drug-resistance element carrying an inverted repetition. J Mol Biol (1975) 11.14
Correct integration of retroviral DNA in vitro. Cell (1987) 10.73
Structure and function of the yeast URA3 gene: expression in Escherichia coli. Gene (1984) 10.07
Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med (1998) 9.72
SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett (1995) 9.62
Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms. Proc Natl Acad Sci U S A (1986) 9.51
A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev (1989) 8.80
Phenotypic analysis of temperature-sensitive yeast actin mutants. Cell (1985) 8.53
Mapping complex genetic traits in humans: new methods using a complete RFLP linkage map. Cold Spring Harb Symp Quant Biol (1986) 8.22
Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am J Hum Genet (1993) 8.05
The Stanford Microarray Database. Nucleic Acids Res (2001) 7.77
Integration of murine leukemia virus DNA depends on mitosis. EMBO J (1993) 7.62